Search CORE

10 research outputs found

Using a business model approach and marketing techniques for recruitment to clinical trials

Author: A Bowling
Alison M McDonald
B McKinstry
C Free
C Speed
C Warlow
Caroline Free
Chris Speed
CJ Dickinson
CRASH-2 trial collaborators
D Francis
DB Hunninghake
DL Sackett
Haleema Shakur
I Roberts
J Sugarman
JF Smyth
LC Lovato
Marion K Campbell
Medicines for Human Use (Clinical Trials) Regulations 2004
MK Campbell
MR Hetzel
Rosemary Knight
S Pocock
S Ross
S Treweek
Shaun Treweek
TV Salomons
V Jenkins
ZJ Penn
Publication venue: 'Springer Science and Business Media LLC'
Publication date: 01/01/2011
Field of study

Peer reviewedPublisher PD

Aberdeen University Research

LSHTM Research Online

Springer - Publisher Connector

Directory of Open Access Journals

University of Dundee Online Publications

Engaging the oldest old in research: lessons from the Newcastle 85+ study

Author: A Bayer
AG Zermansky
B Resnick
C Bartlett
Carol Jagger
Clinical Trials Regulations
CS Jacelon
Department of Health (DoH)
DJH Deeg
F Matthews
I Carpenter
J Bowsher
J Collerton
J Fleming
J Gurwitz
J Xie
JA Adamson
Joan Hughes
Joanna C Collerton
John Bond
Judith M Hunt
June Edwards
K Hancock
Karen Davies
Louise Robinson
M Boles
M Maas
M Ory
MD Chatfield
MRC CFAS
N Hughes
Office for National Statistics
R Harris
S Gueldner
Sally AH Barker
T Gill
T Ostbye
Publication venue: BioMed Central
Publication date: 01/01/2010
Field of study

Springer - Publisher Connector

Current Status of Clinical Trials on Drugs and GCP in China

Author: Factsfigures: Status of China’s economicsocial development in the world.
FW Guo
LD Li
Population pyramid in 1994Population Natural Change from 1984–1994.
Provisions for New Drug Approval.
Regulations governing the registration import,clinical trials in China for foreign drugs.
YM Kong
Publication venue: 'SAGE Publications'
Publication date
Field of study

The Challenge of Auditing Clinical Laboratories

Author: Code of Federal Regulations
Department of HealthHuman Services
Guide de bonne execution des analyses GBEA.
International Air Transport Association.
Note for Guidance: Good Clinical Practice for Trials on Medicinal Products in the European Community.
Organization for Economic Co-OperationDevelopment.
United Kingdom Good Laboratory Practice Compliance Programme
Publication venue: 'SAGE Publications'
Publication date
Field of study

A systematic search for reports of site monitoring technique comparisons in clinical trials

Author: Directive 2001/20/EC of the European Parliament and of the council of 4 April 2001 on the approximation of the laws regulations and administrative provisions of the Member States relating to the implementation of good practice in the conduct of clinical trials on medicinal products for human use
Publication venue: 'SAGE Publications'
Publication date
Field of study

Platelet surface expression of SDF-1 is associated with clinical outcomes in the patients with cardiovascular disease

Author: Angela Bongartz
Christine Zuern
Directive 2001/20/EC of the European Parliament and of the Council of 4th April 2001 on the approximation of the laws regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use
Dominik Rath
Fabian Stimpfle
Karin Müller
Madhumita Chatterjee
Meinrad Gawaz
Michal Droppa
Müller II
Müller KA
Oliver Borst
Sebastian Vogel
Seta N
Tobias Geisler
Zuern CS
Publication venue: 'Informa UK Limited'
Publication date
Field of study

Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches

Author: Alison Backen
Allard
Alpaugh
Andrew Hughes
Brandt
Caroline Dive
Christiansen
Cohen
Cohen
Cristofanilli
Cristofanilli
Daisuke Nonaka
de Bono
De Giorgi
Fidler
Fiona H. Blackhall
Friedl
Glen Clack
Hayes
Hedley
Hofman
Hofman
Hou
Hou
Hou
Ilina
Jian-Mei Hou
Kats-Ugurlu
Krebs
Krebs
Lee Lancashire
Liotta
Liotta
Lynsey Priest
Malcolm Ranson
Matthew G. Krebs
Meng
Mikolajczyk
Miller
Molnar
Muller
Pinzani
Raimondi
Riethdorf
Robert Sloane
Rowand
Stott
The Medicines for Human Use (Clinical Trials) Regulations (UK Gov)
Thiery
Thiery
Tim H. Ward
Vona
Vona
Woywodt
Publication venue: 'Ovid Technologies (Wolters Kluwer Health)'
Publication date
Field of study

Principles of research ethics: A research primer for low- and middle-income countries

Pediatric Drug Development: The International Conference on Harmonization Focus on Clinical Investigations in Children

Author: AL Pereira
AWM Scott
B Geller
BA Larsson
CF Stewart
Clinical Investigation of Medicinal Products in the Pediatric Population: Draft ICH Consensus Guideline.
Committee on Drugs American Academy of Pediatrics.
Committee on Drugs American Academy of Pediatrics.
Committee on Drugs American Academy of Pediatrics.
Convention on the Rights of the Child.
D Berdcl
DB Allen
Declaration of Helsinki revised.
DR Butler
E Samara
GL Kearns
GP Aylward
Guidelines for the clinical evaluation of drugs in pediatric patients.
GW Ladd
H Shirkey
HG Schaefer
IF Litt
International Conference on Harmonization Good Clinical Practices
JD Marshall
JG Simeon
JL Blumer
JP Kemp
JS Leeder
JS Leeder
JT Gilman
JW Finkelstein
KPJ Tercyak
L Zarbatany
LA Weithorn
M Vanelli
MC Manley
MC Nahata
MC Nahata
MD Reed
MD Reed
MR Simar
NC Santanello
Note for guidance on clinical investigation of medicinal products in children.
PD Walson
PL Morselli
PM Wax
PR Stein
R Bishai
RE Kauffman
Regulations requiring manufacturers to assess the safetyeffectiveness of new drugsbiological products in pediatric patients
Report of the Working Party on Registration of Drugs in Children.
ReportRecommendations: Research Involving Children.
SA Amiel
SM Lesko
Specific requirements on contentformat of labeling for human prescription drugs
SS Gidding
Statement by the Steering Committee.
T McRorie
Therapeutic Products Directorate guidelines: Inclusion of pediatric subjects in clinical trials.
Publication venue: 'SAGE Publications'
Publication date
Field of study

Advances and challenges in conducting ethical trials involving populations lacking capacity to consent: A decade in review

Author: Azoulay
Banzi
Berger
Berger
Biros
Bolcic-jankovic
Booth
Bryant
Burns
Chenaud
Ciroldi
Coppolino
Davies
Del Giudice
Department of Health E Welfare, National Commission for the Protection of Human Subjects of B, Behavioral R
Dixon-Woods
Dutton
European Commission
European Parliament and Council of the European Union
Feldman
Gong
Grap
He
Heller
Heyland
Holcomb
Hood
Huls
ICH-GCP
Iverson
Jensen
Johansson
Karlawish
Kim
Kim
Klein
Kohn
Kompanje
Larkin
Lecouturier
Lemaire
Lentz
Lepping
Mehta
Mentzelopoulos
Newman
Phua
Resnik
Ries
Ries
Roberts
Robinson
Rogers
Sachs
Scales
Schandelmaier
Sheehan
Shelton
Shepherd
Shepherd
Shepherd
Shepherd
Shepherd
Shepherd
Shepherd
Shepherd
Spaul
Spong
Stocking
Sugarman
Taylor
The GenOSept National Coordinators
The Medicines for Human Use (Clinical Trials) Amendment (No.2) Regulations
Trivedi
Turnbull
U.S. Department of Health and Human Services Food and Drug Administration
Victoria Shepherd
Werner
Wynn
Yadav
Zimmermann
Publication venue: 'Elsevier BV'
Publication date
Field of study

core

core